Membrane stability of sickle erythrocytes incubated in extracts of three medicinal plants: Anacardium occidentale, Psidium guajava, and Terminalia catappa

Pharmacognosy Magazine

Volumn 7, Issue 26, 2011, Pages 121-125

  Chikezie, Paul Chidoka ^a   Uwakwe, Augustine Amadikwa ^b  

^a IMO STATE UNIVERSITY   (Nigeria)

^b UNIVERSITY OF PORT HARCOURT   (Nigeria)

Author keywords

A. occidentale; Erythrocytes; P. guajava; Saline; T. catappa

Indexed keywords

ANACARDIC ACID; GUAVA EXTRACT; PLANT EXTRACT; TERMINALIA CATAPPA EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASHEW NUT; CELL PROTECTION; CELL SHAPE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; ERYTHROCYTE MEMBRANE; GUAVA; HEMATOLOGICAL PARAMETERS; HEMOLYSIS; HUMAN; HUMAN CELL; MALE; MEAN CORPUSCULAR FRAGILITY INDEX; MEDICINAL PLANT; MEMBRANE STABILIZATION; NONHUMAN; OSMOTIC FRAGILITY; OSMOTIC STRESS; SICKLE CELL; SPECTROPHOTOMETRY; TERMINALIA CATAPPA;

EID: 79956127749     PISSN: 09731296     EISSN: 09764062     Source Type: Journal    
DOI: 10.4103/0973-1296.80669     Document Type: Article

References (38)

1. Weatherall DJ, Abdalla S, Pippard MJ. The anaemia of Plasmodium falciparum malaria. In: Malaria and the red cell. Ciba Symp 1983;94:74-88.
2. Wainscoat JS. The origin of mutant β-globin genes in human population. Acta Haematol 1987;78:154-8. (Pubitemid 18021115)
3. Uzoegwu PN, Onwurah AE. Correlation of lipid peroxidation index with sickle haemoglobin concentrations in malaria-positive and negative statuses of AA, AS and SS individuals from the University of Nigeria, Nsukka community. Res Biotech 2003; 1:97-114.
4. Kutlar A. Sickle cell disease: A multigenic perspective of a single gene disorder. Med Princ Pract 2005;14:15-9. (Pubitemid 41161045)
5. Martins DW. Porphyrins and bile pigments. In: Martin DW, Mayes PA, Rodwell VW, editors. Harper's Review of Biochemistry. Los Altos: Lange Medical Publications;1981. p.212-4
6. Karayakin HN. Cholelithiasis in children with sickle cell disease. Am J Dis Child 1979;133:306-7.
7. Frenette PS, Atweh GF. Sickle cell disease: Old discoveries, new concepts, and future promise. J Clin Invest 2007;117:850-8. (Pubitemid 46556737)
8. Chikezie PC. Studies on the anti-sickling effects of Azadirachta indica and Vernonia amygdalina on HbSS erythrocytes. Inter J Nat Appl Sci 2006;2:24-8.
9. Chikezie PC. Effect of ethanolic extracts of Garcina kola, Cola nitida and Cola acuminata on in vitro haemoglobin S polymerization. Inter J Trop Agric Food Sys 2007;1:220-5.
10. Ekeke GI, Shode FO. The reversion of sickled cells by Cajanus cajan. Planta Medica 1985;6:504-7. (Pubitemid 16176648)
11. Imaga NO, Gbenle GO, Okochi VI, Adenekan SO, Edeoghon SO, Kehinde MO, et al. Antisickling and toxicological profiles of leaf and stem of Parquetina nigrescens L. J Med Plant Res 2010;4:639-43.
12. Okpuzor J, Adebesin O, Ogbunugafor H, Amadi I. The potential of medicinal plants in sickle cell disease control: A review. Inter J Biomed Health Sci 2008;4:47-55.
13. Oyewale JO, Ajibade HA. The osmotic fragility of erythrocytes of turkeys of two age groups. Vet Arhiv 1990; 60: 91-100.
14. Kumar S. An analogy for explaining erythrocyte fragility: Concepts made easy. Adv Physiol Educ 2002;26:134-5.
15. Dacie, JV. The haemolytic anaemias. In: Dacie JV, editor. The Hereditary Haemolytic Anaemias. London, UK: Churchill Livingstone; 1985. Vol. 1, p. 364-418.
16. Krogmeier DE, Mao IL, Bergen WG. Genetic and non genetic effects on erythrocyte osmotic fragility in lactating Holstein cows and its association with yield traits. J Dairy Sci 1993; 76:1994- 2000.
17. Tsakiris S, Giannoulia-Karantana A, Simintzi I, Schulpis KH. The effect of aspartame metabolites on human erythrocyte membrane acetylcholinesterase activity. Pharmacol Res 2006; 53:1-5. (Pubitemid 41619372)
18. Dewey MJ, Brown JL, Nallaseth FS. Genetic differences in red cell osmotic fragility: analysis in allophenic mice. Blood 1982; 59:986-9. (Pubitemid 12125589)
19. Chikezie PC, Uwakwe AA, Monago CC. Studies of human HbAA erythrocytes osmotic fragility index of non malarious blood in the presence of five antimalarial drugs. J Cell Ani Biol 2009; 3:39-43.
20. Pearson ES, Hartley HQ. Biometrika: Tables for Statisticians. Vol 1. 3rd ed. London: Cambridge University Press; 1966.
21. Wȩgrzynowicz R, Marczuk K, Klyszejko B. Osmotic fragility of erythrocytes of bream Abramis brama (L) from Zalew Szczeciński. Acta Ichthyol Piscatoria 1972; 2:95-9.
22. Viscor G, Palomeque J. Method for determining the osmotic fragility curves of erythrocytes in birds. Lab Ani 1982; 16:48-50. (Pubitemid 12153709)
23. Aldrich KJ, Saunders DK, Sievert LM, Sievert G. Comparison of erythrocyte osmotic fragility among amphibians, reptiles, birds and Mammals. Trans Kansas Acad Sci 2006; 109:149-58.
24. Gomes de Sou JR, Pereira LP, da Costa Gomes RB, Pereira LD, Santos-Filho SD. Potential pitfalls on the physiological (osmotic fragility) properties of the red blood cells: Action of a homeopathic medicine. Phcog Mag 2007; 3:182-6.
25. Mota ML, Thomas G, Barbosa-Filho JM. Anti-inflammatory actions of tannins isolated from the bark of Anacardium occidentale L. J Ethnopharmacol 1985; 13:289-300. (Pubitemid 16247101)
26. Rice-Evans C, Omorphos SC, Baysal E. Sickle cells membranes and oxidative damage. Biochem J 1986; 237:265-9. (Pubitemid 16063116)
27. van Kuijk FJ, Sevanian A, Handelman GJ, Dratz EA. A new role for phospholipase A2: Protection of membranes from lipid peroxidation damage. TIBS 1987; 12:31-4. (Pubitemid 17234808)
28. Tamer L, Polat G, Yücebilgiç G, Güvenç B, Başlamişli F. The levels of sera malondialdehyde, erythrocyte membrane Na+-K+/ Mg++ and Ca++/Mg++ adenosine 5' triphosphatase in patients with sickle cell anemia. Turk J Haematol 2000; 17:23-6. (Pubitemid 30186546)
29. Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia arjuna in patients with severe refractory heart failure. Int J Cardiol 1995; 49:191-9.
30. Middleton E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 52:673-751.
31. Rice-Evans C. Flavonoid antioxidants. Curr Med Chem 2001; 8:797-807. (Pubitemid 32427907)
32. Benavente-García O, Castillo J, Marin FR, Ortuño A, Del Río JA. Uses and properties of Citrus flavonoids. J Agric Food Chem 1997; 45:4505-15.
33. Okwu DE. Nigerian medicinal plants I. Med Aromat Plant Sci Biotechnol 2007; 1:90-6.
34. Miliauskas G, Venskutonis PR, van Beek TA. Screening of radical scavenging activity of some medicinal and aromatic plant extracts. Food Chem 2004; 85:231-7. (Pubitemid 37532696)
35. Kumar GS, Jayaveera KN, Ashok CK, Bharathi T, Umachigi SP, Vrushabendra S. Evaluation of antioxidant and antiacne properties of terpenoidal Fraction of Hemidesmus indicus (Indian sarsaparilla). Int J Aesth Antiaging Med 2008; 1:1-8.
36. Awe EO, Makinde JM, Adeloye OA, Banjoko SO. Membrane stabilizing activity of Russelia equisetiformis, Schlecht and Chan. J Nat Prod 2009; 2:203-9.
37. David S. Studies force new view on biology of flavonoids. Bio Med 2007; 541:737-87.
38. Chandran PG, Balaji S. Phytochemical investigation and Pharmacological studies of the flowers of Pithecellobium dulce. Ethnobotanical Leaflets 2008;12:245-53.